Paolo Martelletti | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Optimising migraine treatment: From drug-drug interactions to personalized medicine	THE JOURNAL OF HEADACHE AND PAIN	2019
Drug-Induced Brugada Syndrome in a Psychiatric Patient. a Case Report	SN COMPREHENSIVE CLINICAL MEDICINE	2019
European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention	THE JOURNAL OF HEADACHE AND PAIN	2019
Aids to management of headache disorders in primary care (2nd edition). On behalf of the European Headache Federation and Lifting the Burden: The Global Campaign against Headache	THE JOURNAL OF HEADACHE AND PAIN	2019
Optimizing the long-term management of chronic migraine with onabotulinumtoxinA in real life	EXPERT REVIEW OF NEUROTHERAPEUTICS	2018
Developing a core outcome-domain set to assessing effectiveness of interdisciplinary multimodal pain therapy. the VAPAIN consensus statement on core outcome-domains	PAIN	2018
The journey from genetic predisposition to medication overuse headache to its acquisition as sequela of chronic migraine	THE JOURNAL OF HEADACHE AND PAIN	2018
Serotonin receptor agonists in the acute treatment of migraine. a review on their therapeutic potential	JOURNAL OF PAIN RESEARCH	2018
Changing the approach to anticoagulant therapy in older patients with multimorbidity using a precision medicine approach	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH	2018
Pituitary adenylate-cyclase-activating polypeptide (PACAP). another novel target for treatment of primary headaches?	THE JOURNAL OF HEADACHE AND PAIN	2018
Noninvasive vagus nerve stimulation as acute therapy for migraine. The randomized PRESTO study	NEUROLOGY	2018
Tailoring Treatment in Polymorbid Migraine Patients through Personalized Medicine	CNS DRUGS	2018
Migraine disability complicated by medication overuse	EUROPEAN JOURNAL OF NEUROLOGY	2018
Erenumab is effective in reducing migraine frequency and improving physical functioning	BMJ EVIDENCE-BASED MEDICINE	2018
Latest clinical recommendations on valproate use for migraine prophylaxis in women of childbearing age. Overview from European Medicines Agency and European Headache Federation	THE JOURNAL OF HEADACHE AND PAIN	2018
Effect of exogenous estrogens and progestogens on the course of migraine during reproductive age. A consensus statement by the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESCRH)	THE JOURNAL OF HEADACHE AND PAIN	2018
Guideline on the use of onabotulinumtoxinA in chronic migraine. a consensus statement from the European Headache Federation	THE JOURNAL OF HEADACHE AND PAIN	2018
Practical and clinical utility of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine. A post hoc analysis of the randomized, sham-controlled, double-blind PRESTO trial	THE JOURNAL OF HEADACHE AND PAIN	2018
Consistent effects of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine. additional findings from the randomized, sham-controlled, double-blind PRESTO trial	THE JOURNAL OF HEADACHE AND PAIN	2018
My migraine voice survey. aA global study of disease burden among individuals with migraine for whom preventive treatments have failed	THE JOURNAL OF HEADACHE AND PAIN	2018